Snowden Capital Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$567K Sell
5,195
-1,418
-21% -$135K 0.02% 742
2025
Q4
$536K Sell
6,613
-713
-10% -$61.4K 0.01% 768
2025
Q3
$641K Sell
7,326
-63
-0.9% -$5.63K 0.02% 677
2025
Q2
$614K Sell
7,389
-126
-2% -$10.5K 0.02% 683
2025
Q1
$631K Sell
7,515
-218
-3% -$20.3K 0.02% 644
2024
Q4
$713K Buy
7,733
+751
+11% +$72.2K 0.02% 629
2024
Q3
$649K Sell
6,982
-64
-0.9% -$5.54K 0.02% 660
2024
Q2
$580K Sell
7,046
-419
-6% -$30.8K 0.02% 680
2024
Q1
$495K Sell
7,465
-261
-3% -$16.1K 0.02% 767
2023
Q4
$439K Buy
7,726
+31
+0.4% +$1.62K 0.02% 757
2023
Q3
$419K Sell
7,695
-253
-3% -$15K 0.02% 724
2023
Q2
$535K Sell
7,948
-2,919
-27% -$178K 0.02% 703
2023
Q1
$559K Sell
10,867
-1,295
-11% -$62.9K 0.02% 681
2022
Q4
$560K Buy
12,162
+693
+6% +$32.5K 0.02% 663
2022
Q3
$581K Buy
11,469
+2,634
+30% +$132K 0.03% 587
2022
Q2
$402K Buy
+8,835
New +$395K 0.02% 733

Other funds holding LMAT

Snowden Capital Advisors's LMAT Position: Q1 2026 in Review

Snowden Capital Advisors reduced its LeMaitre Vascular (LMAT) stake by 21% in Q1 2026, selling an estimated $135K and leaving 5,195 shares worth $567K. The position accounts for 0.02% of the portfolio, ranked #742.

Snowden Capital Advisors first reported a position in LMAT in Q2 2022 and has held it in 16 quarters since. The position peaked at $713K in Q4 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Snowden Capital Advisors held 5,195 shares of LeMaitre Vascular worth $567K as of Q1 2026.
  • Snowden Capital Advisors sold 1,418 LeMaitre Vascular shares in Q1 2026, an estimated $135K.
  • LeMaitre Vascular made up 0.02% of Snowden Capital Advisors's portfolio in Q1 2026, its #742 holding.
  • Snowden Capital Advisors first reported a position in LeMaitre Vascular in Q2 2022 and has held it in 16 quarters since.
  • Snowden Capital Advisors's LeMaitre Vascular position peaked at $713K in Q4 2024.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.